Frontiers in Immunology (Jul 2024)

Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen

  • David A. Horwitz,
  • David A. Horwitz,
  • Ju Hua Wang,
  • Dongin Kim,
  • Chang Kang,
  • Katja Brion,
  • Sean Bickerton,
  • Antonio La Cava,
  • Antonio La Cava

DOI
https://doi.org/10.3389/fimmu.2024.1429335
Journal volume & issue
Vol. 15

Abstract

Read online

We have previously reported that nanoparticles (NPs) loaded with IL-2 and TGF-β and targeted to T cells induced polyclonal T regulatory cells (Tregs) that protected mice from graft-versus-host disease (GvHD). Here, we evaluated whether administration of these NPs during alloantigen immunization could prevent allograft rejection by converting immunogenic responses to tolerogenic ones. Using C57BL/6 mice and BALB/c mice as either donors or recipients of allogeneic splenocytes, we found that treatment with the tolerogenic NPs in both strains of mice resulted in a marked inhibition of mixed lymphocyte reaction (MLR) to donor cell alloantigen but not to third-party control mouse cells after transfer of the allogeneic cells. The decreased alloreactivity associated with a four- to fivefold increase in the number of CD4+ and CD8+ T regulatory cells (Tregs) and the acquisition of a tolerogenic phenotype by recipient dendritic cells (DCs) in NP-treated mice. As allogeneic cells persisted in NP-treated mice, these findings suggest that tolerogenic NPs can induce alloantigen-specific Tregs and tolerogenic DCs promoting tolerogenic responses to alloantigen. By inhibiting reactivity to allotransplant, this approach could help reduce the need for immune suppression for the maintenance of allografts.

Keywords